Sean M Kelly

Title: **Innovator Spotlight: Sean M. Kelly**

Introduction

Sean M. Kelly, an innovative inventor based in South San Francisco, California, holds a noteworthy portfolio of three patents in the field of pharmaceuticals. His expertise lies specifically in the development of polymorphs and solid forms of various chemical compounds, contributing significant advancements to the area of medicinal chemistry.

Latest Patents

Sean's latest patent focuses on the crystalline polymorph forms of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, known as GDC-0077. This patented innovation encompasses methods for producing these crystalline forms, which may include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts. The invention promises to enhance the efficacy and stability of this compound's applications in pharmaceuticals.

Career Highlights

Sean M. Kelly works at Genentech, Inc., a leading biotechnology company renowned for its commitment to transforming the lives of people with serious diseases. His role in the organization has allowed him to advance research and development projects that create impactful medical solutions. His focus on polymorph research reflects his dedication to improving therapeutic agents and their formulations.

Collaborations

Throughout his career, Sean has collaborated with notable industry professionals, including Chong Han and Scott J. Savage. These partnerships have furthered innovative research and development, combining their expertise to convert concepts into tangible medical advancements.

Conclusion

Sean M. Kelly exemplifies the spirit of innovation through his dedicated work in pharmaceuticals. With his significant contributions to the field, he continues to inspire fellow inventors and researchers, reinforcing the vital role of patenting in ensuring that groundbreaking inventions reach the market for the benefit of society.